In a study performed in rabbits with chronic heart failure, central administration of losartan, superoxide dismutase mimetic tempol, or NADPH oxidase inhibitor APO, reduced sympathetic nerve activity and oxidative stress (Gao et al., 2004). Here, FMO5 is linked to congestive heart failure.